Quest Diagnostics Incorporated updated earnings guidance for the full year of 2024. For the year, the company expects net revenues to be between $9.40 billion to $9.48 billion, Net revenues increase to be between 1.6% to 2.5%, Reported diluted EPS to be between $7.57 to $7.82 compared to the previous guidance of net revenues to be between $9.35 billion to $9.45 billion, Net revenues increase to be between 1.1% to 2.1%, Reported diluted EPS to be between $7.69 to $7.99.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
140.8 USD | +1.16% | +3.41% | +2.10% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.10% | 15.46B | |
-28.75% | 70.3B | |
+2.04% | 27.46B | |
-6.19% | 17.8B | |
+2.32% | 17.46B | |
+7.06% | 13.49B | |
+10.80% | 13.06B | |
+71.31% | 12.96B | |
+75.96% | 12.56B | |
+1.87% | 12.14B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024